The Trump administration’s proposed cuts at the National Institutes of Health and Food and Drug Administration could lower the number of new drugs that come to market in ...

Sarepta Therapeutics Inc. has refused to pause all shipments of its Elevidys treatment after three deaths were linked to the company’s gene therapies, the Food and Drug Administration said Friday.